"Linezolid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An oxazolidinone and acetamide derived ANTI-BACTERIAL AGENT and PROTEIN SYNTHESIS INHIBITOR that is used in the treatment of GRAM-POSITIVE BACTERIAL INFECTIONS of the skin and respiratory tract.
| Descriptor ID |
D000069349
|
| MeSH Number(s) |
D02.065.064.463 D02.241.081.018.110.525 D03.383.129.462.600.550
|
| Concept/Terms |
Linezolid- Linezolid
- N-((3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide
- Linezolide
U 100766- U 100766
- 100766, U
- PNU-100766
- PNU 100766
- PNU100766
- U-100766
- U100766
|
Below are MeSH descriptors whose meaning is more general than "Linezolid".
Below are MeSH descriptors whose meaning is more specific than "Linezolid".
This graph shows the total number of publications written about "Linezolid" by people in this website by year, and whether "Linezolid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2011 | 0 | 3 | 3 |
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2017 | 14 | 6 | 20 |
| 2018 | 8 | 9 | 17 |
| 2019 | 8 | 6 | 14 |
| 2020 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Linezolid" by people in Profiles.
-
Potential activity of Linezolid against SARS-CoV-2 using electronic and molecular docking study. J Mol Model. 2021 Jul 08; 27(8):222.
-
Colonization by multidrug-resistant microorganisms in ICU patients during the COVID-19 pandemic. Med Intensiva (Engl Ed). 2021 Jun-Jul; 45(5):313-315.
-
Different incidences of acute kidney injury (AKI) and outcomes in COVID-19 patients with and without non-azithromycin antibiotics: A retrospective study. J Med Virol. 2021 Jul; 93(7):4411-4419.
-
Linezolid a potential treatment for COVID-19 coinfections. Braz J Anesthesiol. 2021 Mar-Apr; 71(2):198.
-
Medical treatment of 55 patients with COVID-19 from seven cities in northeast China who fully recovered: A single-center, retrospective, observational study. Medicine (Baltimore). 2021 Jan 15; 100(2):e23923.
-
Hospital-acquired Skin and Skin-structure Infection in COVID-19 Infected Patient with Prolonged Hospitalization. Acta Med Indones. 2021 Jan; 53(1):105-107.
-
Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship. Eur J Clin Microbiol Infect Dis. 2021 Apr; 40(4):859-869.
-
Panton-Valentine Leukocidin-Secreting Staphylococcus aureus Pneumonia Complicating COVID-19. Emerg Infect Dis. 2020 Aug; 26(8):1939-1941.
-
Proactive therapeutic drug monitoring (TDM) may be helpful in managing long-term treatment with linezolid safely: findings from a monocentric, prospective, open-label, interventional study. J Antimicrob Chemother. 2019 12 01; 74(12):3588-3595.
-
Linezolid Dosing in Patients With Liver Cirrhosis: Standard Dosing Risk Toxicity. Ther Drug Monit. 2019 12; 41(6):732-739.